Invention Grant
- Patent Title: Macrocyclic hepatitis C serine protease inhibitors
-
Application No.: US14299095Application Date: 2014-06-09
-
Publication No.: US09493506B2Publication Date: 2016-11-15
- Inventor: Hui-Ju Chen , Keith F. McDaniel , Brian E. Green , Jason P. Shanley , Albert W. Kruger , Jorge Gandarilla , Dennie S. Welch , Russell D. Cink , Steven C. Cullen , Yonghua Gai , Guoqiang Wang , Yat Sun Or
- Applicant: Enanta Pharmaceuticals, Inc. , AbbVie, Inc.
- Applicant Address: US IL Abbott Park US MA Watertown
- Assignee: AbbVie Inc.,Enata Pharmacueticals, Inc.
- Current Assignee: AbbVie Inc.,Enata Pharmacueticals, Inc.
- Current Assignee Address: US IL Abbott Park US MA Watertown
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07K5/083
Abstract:
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Public/Granted literature
- US20140287992A1 MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS Public/Granted day:2014-09-25
Information query
